Cerenome (XMP1) Stock Forecast & Price Target
XMP1 Analyst Ratings
Strong Buy
3Buy0Hold0Sell
Based on 3 analysts giving stock ratings to Cerenome in the past 3 months
XMP1 Stock 12 Month Forecast
Average Price Target
EUR 25.67â–˛(1660.50% Upside)Based on 3 Wall Street analysts offering 12 month price targets for Cerenome in the last 3 months. The average price target is EUR 25.67 with a high forecast of EUR 38.50 and a low forecast of EUR 10.74. The average price target represents a 1660.50% change from the last price of EUR 1.46.
Past 12 Months12 Month ForecastJan2026Oct2026
HighEUR 38.50
AverageEUR 25.67
LowEUR 10.74
Highest Price TargetHighestEUR 38.50Average Price TargetEUR 25.67Lowest Price TargetLowestEUR 10.74
Detailed List of Analyst Forecasts​
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Jason McCarthy | Maxim Group | EUR 10.74 | buy | 636.95%Upside | Reiterated | 10/29/26 | ||
| Chad Messer | Lake Street | EUR 44.77→EUR 27.76 | buy | 1803.80%Upside | Reiterated | 10/01/26 | ||
| Edward Woo | Ascendiant | EUR 51.04→EUR 38.50 | buy | 2540.75%Upside | Reiterated | 09/10/26 | ||
| Jason Kolbert | D. Boral Capital | ― | hold | ― | Downgraded | 03/31/26 | ||
| Sean Lee CFA | H.C. Wainwright | EUR 22.38 | buy | 1435.32%Upside | Reiterated | 03/16/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Jason McCarthy | 10/29/26 | EUR 10.74 | buy | 636.95%Upside | Reiterated | Maxim Group | ||
| Chad Messer | 10/01/26 | EUR 44.77→EUR 27.76 | buy | 1803.80%Upside | Reiterated | Lake Street | ||
| Edward Woo | 09/10/26 | EUR 51.04→EUR 38.50 | buy | 2540.75%Upside | Reiterated | Ascendiant | ||
| Jason Kolbert | 03/31/26 | ― | hold | ― | Downgraded | D. Boral Capital | ||
| Sean Lee CFA | 03/16/26 | EUR 22.38 | buy | 1435.32%Upside | Reiterated | H.C. Wainwright |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Cerenome
3 Months
Success Rate4/11 ratings generated profit
36%
Average Return
-25.07%
Copying Jason McCarthy's trades and holding each position for 3 Months would result in 36.36% of your transactions generating a profit, with an average return of -25.07% per trade.
1 Year
Success Rate1/24 ratings generated profit
4%
Average Return
-64.62%
Copying Sean Lee CFA's trades and holding each position for 1 Year would result in 4.17% of your transactions generating a profit, with an average return of -64.62% per trade.
2 Years
Success Rate0/14 ratings generated profit
0%
Average Return
-76.43%
Copying Edward Woo's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -76.43% per trade.
XMP1 Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 5 | 2 | 2 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 5 | 2 | 2 | 3 | 3 |
In the current month, XMP1 has received 3 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. XMP1 average Analyst price target in the past 3 months is 25.67.
XMP1 Financial Forecast
ConsensusEUR 0.00
XMP1 Sales Forecast
Next quarter’s sales forecast for XMP1 is EUR 0 with a range of ― to ―. The previous quarter’s sales results were EUR 366.96K. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
XMP1 Stock Forecast FAQ
What is DE:XMP1’s average 12-month price target, according to analysts?
Based on analyst ratings, Cerenome’s 12-month average price target is €25.67.
What is DE:XMP1’s upside potential, based on the analysts’ average price target?
Cerenome has 1660.50% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Cerenome a Buy, Sell or Hold?
Cerenome has a consensus rating of Strong Buy, which is based on 3 buy ratings, 0 hold ratings and 0 sell ratings.
What is Cerenome’s share price target?
The average share price target for Cerenome is €25.67. This is based on 3 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €38.50, and the lowest forecast is €10.74. The average share price target represents a 1660.50% increase from the current price of €1.458.
What do analysts say about Cerenome?
Cerenome’s analyst rating consensus is a Strong Buy. This is based on the ratings of 3 Wall Street analysts.
How can I buy shares of Cerenome?
To buy shares of DE:XMP1, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
